Segment Reporting Disclosure [Text Block] |
6. REPORTABLE SEGMENTS
The Company operates in two business segments: referenced neurometric information services and clinical services. Neurometric Information Services, provides data, in the form of a PEER Report, to psychiatrists and other physicians/prescribers to enable them to make a more informed decision when treating a specific patient with mental, behavioral and/or addictive disorders. Clinic operates NTC, a full service psychiatric practice.
The following tables show operating results for the Company’s reportable segments, along with reconciliation from segment gross profit (loss) from operations, the most directly comparable measure in accordance with generally accepted accounting principles in the United States, or GAAP:
|
|
Three months ended March 31, 2012 |
|
|
Reference Neurometric |
|
Clinic |
|
Eliminations |
|
Total |
Revenues |
|
|
37,200 |
|
|
|
188,900 |
|
|
|
(12,000 |
) |
|
|
214,100 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenues |
|
|
35,900 |
|
|
|
12,000 |
|
|
|
(12,000 |
) |
|
|
35,900 |
|
Research |
|
|
67,400 |
|
|
|
— |
|
|
|
— |
|
|
|
67,400 |
|
Product Development |
|
|
162,800 |
|
|
|
— |
|
|
|
— |
|
|
|
162,800 |
|
Sales and marketing |
|
|
304,200 |
|
|
|
10,800 |
|
|
|
— |
|
|
|
315,000 |
|
General and administrative |
|
|
788,800 |
|
|
|
262,200 |
|
|
|
— |
|
|
|
1,051,000 |
|
Total operating expenses |
|
|
1,359,100 |
|
|
|
285,000 |
|
|
|
(12,000 |
) |
|
|
1,632,100 |
|
Loss from operations |
|
$ |
(1,321,900 |
) |
|
$ |
(96,100 |
) |
|
$ |
— |
|
|
$ |
(1,418,000 |
) |
|
|
Three months ended March 31, 2011 |
|
|
Reference Neurometric |
|
Clinic |
|
Eliminations |
|
Total |
Revenues |
|
|
38,400 |
|
|
|
162,600 |
|
|
|
(9,200 |
) |
|
|
191,800 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenues |
|
|
36,500 |
|
|
|
9,200 |
|
|
|
(9,200 |
) |
|
|
36,500 |
|
Research |
|
|
119,300 |
|
|
|
— |
|
|
|
— |
|
|
|
119,300 |
|
Product Development |
|
|
116,400 |
|
|
|
— |
|
|
|
— |
|
|
|
116,400 |
|
Sales and marketing |
|
|
321,400 |
|
|
|
26,100 |
|
|
|
— |
|
|
|
347,500 |
|
General and administrative |
|
|
764,500 |
|
|
|
314,700 |
|
|
|
— |
|
|
|
1,079,200 |
|
Total operating expenses |
|
|
1,358,100 |
|
|
|
350,000 |
|
|
|
(9,200 |
) |
|
|
1,698,900 |
|
Loss from operations |
|
$ |
(1,319,700 |
) |
|
$ |
(187,400 |
) |
|
$ |
— |
|
|
$ |
(1,507,100 |
) |
|
|
Six months ended March 31, 2012 |
|
|
Reference Neurometric |
|
Clinic |
|
Eliminations |
|
Total |
Revenues |
|
|
75,200 |
|
|
|
341,200 |
|
|
|
(18,000 |
) |
|
|
398,400 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenues |
|
|
75,100 |
|
|
|
18,000 |
|
|
|
(18,000 |
) |
|
|
75,100 |
|
Research |
|
|
137,100 |
|
|
|
— |
|
|
|
— |
|
|
|
137,100 |
|
Product Development |
|
|
275,300 |
|
|
|
— |
|
|
|
— |
|
|
|
275,300 |
|
Sales and marketing |
|
|
590,400 |
|
|
|
54,700 |
|
|
|
— |
|
|
|
645,100 |
|
General and administrative |
|
|
1,597,200 |
|
|
|
514,800 |
|
|
|
— |
|
|
|
2,112,000 |
|
Total operating expenses |
|
|
2,675,100 |
|
|
|
587,500 |
|
|
|
(18,000 |
) |
|
|
3,244,600 |
|
Loss from operations |
|
$ |
(2,599,900 |
) |
|
$ |
(246,300 |
) |
|
$ |
— |
|
|
$ |
(2,846,200 |
)
|
Six months ended March 31, 2011 |
|
|
Reference Neurometric |
|
Clinic |
|
Eliminations |
|
Total |
Revenues |
|
|
72,800 |
|
|
|
283,200 |
|
|
|
(16,400 |
) |
|
|
339,600 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenues |
|
|
72,500 |
|
|
|
16,400 |
|
|
|
(16,400 |
) |
|
|
72,500 |
|
Research |
|
|
330,300 |
|
|
|
— |
|
|
|
— |
|
|
|
330,300 |
|
Product Development |
|
|
260,800 |
|
|
|
— |
|
|
|
— |
|
|
|
260,800 |
|
Sales and marketing |
|
|
565,100 |
|
|
|
29,200 |
|
|
|
— |
|
|
|
594,300 |
|
General and administrative |
|
|
1,597,500 |
|
|
|
535,600 |
|
|
|
— |
|
|
|
2,133,100 |
|
Total operating expenses |
|
|
2,826,200 |
|
|
|
581,200 |
|
|
|
(16,400 |
) |
|
|
3,391,000 |
|
Loss from operations |
|
$ |
(2,753,400 |
) |
|
$ |
(298,000 |
) |
|
$ |
— |
|
|
$ |
(3,051,400 |
) |
The following table includes selected segment financial information as of March 31, 2012, related to total assets:
|
|
Reference Neurometric |
|
Clinic |
|
Total |
Total assets |
|
$ |
645,400 |
|
|
$ |
59,500 |
|
|
$ |
704,900 |
|
|
The Company operates in two business segments: reference neurometric and clinic. Neurometric Information Services (formerly called Laboratory Information Services) provides data to psychiatrists and other physicians/prescribers to enable them to make a more informed decision when treating a specific patient with mental, behavioral and/or addictive disorders provides reports (“Peer Reports”). The Clinic segment operates NTC, a full service psychiatric practice.
The following tables show operating results for the Company’s reportable segments, along with reconciliation from segment gross profit to (loss) from operations, the most directly comparable measure in accordance with generally accepted accounting principles in the United States, or GAAP:
|
|
Year ended September 30, 2011 |
|
|
|
Neurometric Information Services |
|
|
Clinic |
|
|
Eliminations |
|
|
Total |
|
Revenues |
|
|
146,200 |
|
|
|
634,500 |
|
|
|
(34,800 |
) |
|
|
745,900 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenues |
|
|
147,100 |
|
|
|
34,800 |
|
|
|
(34,800 |
) |
|
|
147,100 |
|
Research |
|
|
482,800 |
|
|
|
- |
|
|
|
- |
|
|
|
482,800 |
|
Product development |
|
|
442,000 |
|
|
|
- |
|
|
|
- |
|
|
|
442,000 |
|
Sales and marketing |
|
|
1,132,800 |
|
|
|
98,700 |
|
|
|
- |
|
|
|
1,231,500 |
|
General and administrative |
|
|
3,197,900 |
|
|
|
1,074,000 |
|
|
|
|
|
|
|
4,271,900 |
|
Total operating expenses |
|
|
5,402,600 |
|
|
|
1,207,500 |
|
|
|
(34,800 |
) |
|
|
6,575,300 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations |
|
$ |
(5,256,400 |
) |
|
$ |
(573,000 |
) |
|
$ |
0 |
|
|
$ |
(5,829,400 |
) |
|
|
Year ended September 30, 2010 |
|
|
|
Neurometric Information |
|
|
|
|
|
|
|
|
|
|
|
|
Services |
|
|
Clinic |
|
|
Eliminations |
|
|
Total |
|
Revenues |
|
|
156,000 |
|
|
|
535,700 |
|
|
|
(53,200 |
) |
|
|
638,500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenues |
|
|
135,100 |
|
|
|
19,900 |
|
|
|
(19,900 |
) |
|
|
135,100 |
|
Research and development |
|
|
738,800 |
|
|
|
- |
|
|
|
- |
|
|
|
738,800 |
|
Product development |
|
|
381,700 |
|
|
|
- |
|
|
|
- |
|
|
|
381,700 |
|
Sales and marketing |
|
|
853,100 |
|
|
|
17,800 |
|
|
|
- |
|
|
|
870,900 |
|
General and administrative |
|
|
4,296,200 |
|
|
|
754,100 |
|
|
|
(33,300 |
) |
|
|
5,017,000 |
|
Total operating expenses |
|
|
6,404,900 |
|
|
|
791,800 |
|
|
|
(53,200 |
) |
|
|
7,143,500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations |
|
$ |
(6,248,900 |
) |
|
$ |
(256,100 |
) |
|
$ |
0 |
|
|
$ |
(6,505,000 |
) |
The following table includes selected segment financial information as of September 30, 2011, related to total assets:
|
|
Reference Neurometric |
|
|
Clinic |
|
|
Total |
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
308,800 |
|
|
$ |
61,200 |
|
|
$ |
370,000 |
|
|